nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2B6—Thiotepa—sarcoma	0.267	0.292	CbGbCtD
Carbinoxamine—CYP2E1—Dacarbazine—sarcoma	0.15	0.164	CbGbCtD
Carbinoxamine—CYP2E1—Mitoxantrone—sarcoma	0.116	0.127	CbGbCtD
Carbinoxamine—CYP3A4—Thiotepa—sarcoma	0.082	0.0898	CbGbCtD
Carbinoxamine—CYP2E1—Etoposide—sarcoma	0.0734	0.0803	CbGbCtD
Carbinoxamine—CYP2C8—Etoposide—sarcoma	0.0548	0.06	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—sarcoma	0.0494	0.054	CbGbCtD
Carbinoxamine—CYP3A4—Mitoxantrone—sarcoma	0.0353	0.0386	CbGbCtD
Carbinoxamine—CYP3A4—Vincristine—sarcoma	0.0243	0.0266	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—sarcoma	0.0239	0.0261	CbGbCtD
Carbinoxamine—CYP3A4—Etoposide—sarcoma	0.0222	0.0243	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—sarcoma	0.0152	0.0166	CbGbCtD
Carbinoxamine—Neuritis—Vincristine—sarcoma	0.00217	0.0252	CcSEcCtD
Carbinoxamine—Chest discomfort—Etoposide—sarcoma	0.00148	0.0172	CcSEcCtD
Carbinoxamine—Urinary retention—Thiotepa—sarcoma	0.00126	0.0147	CcSEcCtD
Carbinoxamine—Urinary retention—Vincristine—sarcoma	0.00112	0.013	CcSEcCtD
Carbinoxamine—Neuritis—Epirubicin—sarcoma	0.000986	0.0114	CcSEcCtD
Carbinoxamine—Sweating increased—Mitoxantrone—sarcoma	0.000965	0.0112	CcSEcCtD
Carbinoxamine—Agranulocytosis—Thiotepa—sarcoma	0.000954	0.0111	CcSEcCtD
Carbinoxamine—Agranulocytosis—Dactinomycin—sarcoma	0.000947	0.011	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Vincristine—sarcoma	0.000928	0.0108	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—sarcoma	0.000912	0.0106	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Vincristine—sarcoma	0.000889	0.0103	CcSEcCtD
Carbinoxamine—Drowsiness—Mitoxantrone—sarcoma	0.000883	0.0103	CcSEcCtD
Carbinoxamine—Tinnitus—Thiotepa—sarcoma	0.000856	0.00994	CcSEcCtD
Carbinoxamine—Agranulocytosis—Mitoxantrone—sarcoma	0.000824	0.00957	CcSEcCtD
Carbinoxamine—Chills—Thiotepa—sarcoma	0.000823	0.00957	CcSEcCtD
Carbinoxamine—Chills—Dactinomycin—sarcoma	0.000817	0.00949	CcSEcCtD
Carbinoxamine—Sweating increased—Etoposide—sarcoma	0.000802	0.00932	CcSEcCtD
Carbinoxamine—Tension—Thiotepa—sarcoma	0.000784	0.00911	CcSEcCtD
Carbinoxamine—Nervousness—Thiotepa—sarcoma	0.000776	0.00901	CcSEcCtD
Carbinoxamine—Vision blurred—Thiotepa—sarcoma	0.000753	0.00875	CcSEcCtD
Carbinoxamine—Agitation—Thiotepa—sarcoma	0.000734	0.00853	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Etoposide—sarcoma	0.00072	0.00836	CcSEcCtD
Carbinoxamine—Chills—Mitoxantrone—sarcoma	0.000711	0.00826	CcSEcCtD
Carbinoxamine—Convulsion—Thiotepa—sarcoma	0.000692	0.00804	CcSEcCtD
Carbinoxamine—Agranulocytosis—Etoposide—sarcoma	0.000685	0.00796	CcSEcCtD
Carbinoxamine—Confusional state—Thiotepa—sarcoma	0.000657	0.00764	CcSEcCtD
Carbinoxamine—Agitation—Vincristine—sarcoma	0.000651	0.00756	CcSEcCtD
Carbinoxamine—Vision blurred—Mitoxantrone—sarcoma	0.00065	0.00755	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Thiotepa—sarcoma	0.000638	0.00742	CcSEcCtD
Carbinoxamine—Vertigo—Vincristine—sarcoma	0.000636	0.00739	CcSEcCtD
Carbinoxamine—Tachycardia—Thiotepa—sarcoma	0.000636	0.00739	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dactinomycin—sarcoma	0.000634	0.00736	CcSEcCtD
Carbinoxamine—Anorexia—Thiotepa—sarcoma	0.000622	0.00722	CcSEcCtD
Carbinoxamine—Anorexia—Dactinomycin—sarcoma	0.000617	0.00717	CcSEcCtD
Carbinoxamine—Convulsion—Vincristine—sarcoma	0.000614	0.00713	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—sarcoma	0.000608	0.00707	CcSEcCtD
Carbinoxamine—Convulsion—Mitoxantrone—sarcoma	0.000598	0.00694	CcSEcCtD
Carbinoxamine—Chills—Etoposide—sarcoma	0.000592	0.00687	CcSEcCtD
Carbinoxamine—Paraesthesia—Thiotepa—sarcoma	0.000585	0.0068	CcSEcCtD
Carbinoxamine—Somnolence—Thiotepa—sarcoma	0.00058	0.00673	CcSEcCtD
Carbinoxamine—Dyspepsia—Thiotepa—sarcoma	0.000574	0.00667	CcSEcCtD
Carbinoxamine—Confusional state—Mitoxantrone—sarcoma	0.000568	0.0066	CcSEcCtD
Carbinoxamine—Decreased appetite—Thiotepa—sarcoma	0.000567	0.00658	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Vincristine—sarcoma	0.000566	0.00658	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—sarcoma	0.000563	0.00654	CcSEcCtD
Carbinoxamine—Decreased appetite—Dactinomycin—sarcoma	0.000563	0.00653	CcSEcCtD
Carbinoxamine—Fatigue—Thiotepa—sarcoma	0.000562	0.00653	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Vincristine—sarcoma	0.000559	0.00649	CcSEcCtD
Carbinoxamine—Fatigue—Dactinomycin—sarcoma	0.000558	0.00648	CcSEcCtD
Carbinoxamine—Constipation—Thiotepa—sarcoma	0.000558	0.00648	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000551	0.0064	CcSEcCtD
Carbinoxamine—Anorexia—Vincristine—sarcoma	0.000551	0.0064	CcSEcCtD
Carbinoxamine—Tachycardia—Mitoxantrone—sarcoma	0.00055	0.00638	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000544	0.00632	CcSEcCtD
Carbinoxamine—Hypotension—Vincristine—sarcoma	0.00054	0.00628	CcSEcCtD
Carbinoxamine—Feeling abnormal—Thiotepa—sarcoma	0.000537	0.00624	CcSEcCtD
Carbinoxamine—Anorexia—Mitoxantrone—sarcoma	0.000537	0.00623	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—sarcoma	0.000534	0.00621	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dactinomycin—sarcoma	0.000533	0.00619	CcSEcCtD
Carbinoxamine—Hypotension—Mitoxantrone—sarcoma	0.000526	0.00611	CcSEcCtD
Carbinoxamine—Insomnia—Vincristine—sarcoma	0.000523	0.00607	CcSEcCtD
Carbinoxamine—Paraesthesia—Vincristine—sarcoma	0.000519	0.00603	CcSEcCtD
Carbinoxamine—Urticaria—Thiotepa—sarcoma	0.000518	0.00602	CcSEcCtD
Carbinoxamine—Vertigo—Etoposide—sarcoma	0.000516	0.00599	CcSEcCtD
Carbinoxamine—Paraesthesia—Mitoxantrone—sarcoma	0.000506	0.00587	CcSEcCtD
Carbinoxamine—Decreased appetite—Vincristine—sarcoma	0.000503	0.00584	CcSEcCtD
Carbinoxamine—Somnolence—Mitoxantrone—sarcoma	0.000501	0.00581	CcSEcCtD
Carbinoxamine—Fatigue—Vincristine—sarcoma	0.000498	0.00579	CcSEcCtD
Carbinoxamine—Convulsion—Etoposide—sarcoma	0.000497	0.00578	CcSEcCtD
Carbinoxamine—Dyspepsia—Mitoxantrone—sarcoma	0.000496	0.00576	CcSEcCtD
Carbinoxamine—Constipation—Vincristine—sarcoma	0.000494	0.00574	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—sarcoma	0.000494	0.00574	CcSEcCtD
Carbinoxamine—Decreased appetite—Mitoxantrone—sarcoma	0.000489	0.00569	CcSEcCtD
Carbinoxamine—Fatigue—Mitoxantrone—sarcoma	0.000485	0.00564	CcSEcCtD
Carbinoxamine—Constipation—Mitoxantrone—sarcoma	0.000482	0.00559	CcSEcCtD
Carbinoxamine—Confusional state—Etoposide—sarcoma	0.000472	0.00549	CcSEcCtD
Carbinoxamine—Asthenia—Thiotepa—sarcoma	0.000468	0.00543	CcSEcCtD
Carbinoxamine—Asthenia—Dactinomycin—sarcoma	0.000464	0.00539	CcSEcCtD
Carbinoxamine—Feeling abnormal—Mitoxantrone—sarcoma	0.000464	0.00539	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Etoposide—sarcoma	0.000459	0.00533	CcSEcCtD
Carbinoxamine—Tachycardia—Etoposide—sarcoma	0.000457	0.00531	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Etoposide—sarcoma	0.000453	0.00526	CcSEcCtD
Carbinoxamine—Urticaria—Mitoxantrone—sarcoma	0.000447	0.0052	CcSEcCtD
Carbinoxamine—Anorexia—Etoposide—sarcoma	0.000446	0.00519	CcSEcCtD
Carbinoxamine—Diarrhoea—Thiotepa—sarcoma	0.000446	0.00518	CcSEcCtD
Carbinoxamine—Diarrhoea—Dactinomycin—sarcoma	0.000443	0.00514	CcSEcCtD
Carbinoxamine—Hypotension—Etoposide—sarcoma	0.000438	0.00508	CcSEcCtD
Carbinoxamine—Dizziness—Thiotepa—sarcoma	0.000431	0.00501	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—sarcoma	0.000426	0.00495	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—sarcoma	0.000421	0.0049	CcSEcCtD
Carbinoxamine—Paraesthesia—Etoposide—sarcoma	0.000421	0.00489	CcSEcCtD
Carbinoxamine—Somnolence—Etoposide—sarcoma	0.000416	0.00484	CcSEcCtD
Carbinoxamine—Asthenia—Vincristine—sarcoma	0.000415	0.00482	CcSEcCtD
Carbinoxamine—Vomiting—Thiotepa—sarcoma	0.000415	0.00482	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—sarcoma	0.000412	0.00478	CcSEcCtD
Carbinoxamine—Vomiting—Dactinomycin—sarcoma	0.000411	0.00478	CcSEcCtD
Carbinoxamine—Headache—Thiotepa—sarcoma	0.000408	0.00474	CcSEcCtD
Carbinoxamine—Decreased appetite—Etoposide—sarcoma	0.000407	0.00473	CcSEcCtD
Carbinoxamine—Asthenia—Mitoxantrone—sarcoma	0.000404	0.00469	CcSEcCtD
Carbinoxamine—Fatigue—Etoposide—sarcoma	0.000404	0.00469	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—sarcoma	0.000404	0.00469	CcSEcCtD
Carbinoxamine—Constipation—Etoposide—sarcoma	0.000401	0.00465	CcSEcCtD
Carbinoxamine—Diarrhoea—Vincristine—sarcoma	0.000396	0.0046	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—sarcoma	0.000395	0.00458	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00039	0.00453	CcSEcCtD
Carbinoxamine—Nausea—Thiotepa—sarcoma	0.000387	0.0045	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etoposide—sarcoma	0.000386	0.00448	CcSEcCtD
Carbinoxamine—Diarrhoea—Mitoxantrone—sarcoma	0.000385	0.00448	CcSEcCtD
Carbinoxamine—Nausea—Dactinomycin—sarcoma	0.000384	0.00447	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—sarcoma	0.000384	0.00446	CcSEcCtD
Carbinoxamine—Dizziness—Vincristine—sarcoma	0.000382	0.00444	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—sarcoma	0.000381	0.00442	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000373	0.00434	CcSEcCtD
Carbinoxamine—Urticaria—Etoposide—sarcoma	0.000372	0.00432	CcSEcCtD
Carbinoxamine—Vomiting—Vincristine—sarcoma	0.000368	0.00427	CcSEcCtD
Carbinoxamine—Headache—Vincristine—sarcoma	0.000362	0.00421	CcSEcCtD
Carbinoxamine—Vomiting—Mitoxantrone—sarcoma	0.000358	0.00416	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—sarcoma	0.000355	0.00413	CcSEcCtD
Carbinoxamine—Headache—Mitoxantrone—sarcoma	0.000353	0.0041	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—sarcoma	0.000345	0.004	CcSEcCtD
Carbinoxamine—Nausea—Vincristine—sarcoma	0.000343	0.00399	CcSEcCtD
Carbinoxamine—Asthenia—Etoposide—sarcoma	0.000336	0.0039	CcSEcCtD
Carbinoxamine—Nausea—Mitoxantrone—sarcoma	0.000334	0.00389	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—sarcoma	0.000332	0.00385	CcSEcCtD
Carbinoxamine—Diarrhoea—Etoposide—sarcoma	0.00032	0.00372	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—sarcoma	0.000319	0.0037	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—sarcoma	0.000316	0.00367	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—sarcoma	0.000312	0.00363	CcSEcCtD
Carbinoxamine—Dizziness—Etoposide—sarcoma	0.00031	0.0036	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—sarcoma	0.000307	0.00356	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—sarcoma	0.000303	0.00352	CcSEcCtD
Carbinoxamine—Vomiting—Etoposide—sarcoma	0.000298	0.00346	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—sarcoma	0.000296	0.00343	CcSEcCtD
Carbinoxamine—Headache—Etoposide—sarcoma	0.000293	0.00341	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—sarcoma	0.000292	0.00339	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—sarcoma	0.000289	0.00336	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—sarcoma	0.000289	0.00336	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—sarcoma	0.000284	0.0033	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—sarcoma	0.000281	0.00326	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—sarcoma	0.000279	0.00324	CcSEcCtD
Carbinoxamine—Nausea—Etoposide—sarcoma	0.000278	0.00323	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—sarcoma	0.000274	0.00318	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—sarcoma	0.000267	0.00311	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—sarcoma	0.000265	0.00308	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—sarcoma	0.000263	0.00306	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—sarcoma	0.000258	0.003	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—sarcoma	0.000257	0.00299	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—sarcoma	0.000256	0.00298	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—sarcoma	0.000254	0.00295	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—sarcoma	0.00025	0.00291	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—sarcoma	0.000245	0.00285	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—sarcoma	0.000245	0.00285	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—sarcoma	0.000238	0.00276	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—sarcoma	0.000237	0.00276	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—sarcoma	0.000237	0.00275	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—sarcoma	0.000236	0.00274	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—sarcoma	0.000235	0.00273	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—sarcoma	0.000233	0.00271	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—sarcoma	0.000232	0.00269	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—sarcoma	0.000231	0.00268	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—sarcoma	0.000228	0.00265	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—sarcoma	0.000227	0.00264	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—sarcoma	0.000226	0.00263	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—sarcoma	0.000225	0.00261	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—sarcoma	0.00022	0.00255	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—sarcoma	0.000218	0.00253	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—sarcoma	0.000216	0.00251	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—sarcoma	0.000216	0.00251	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—sarcoma	0.000214	0.00248	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—sarcoma	0.000211	0.00245	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—sarcoma	0.000209	0.00243	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—sarcoma	0.000209	0.00242	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—sarcoma	0.000208	0.00241	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—sarcoma	0.0002	0.00233	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—sarcoma	0.000193	0.00224	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—sarcoma	0.000188	0.00219	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—sarcoma	0.00018	0.00209	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—sarcoma	0.000174	0.00202	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—sarcoma	0.000174	0.00202	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—sarcoma	0.000167	0.00194	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—sarcoma	0.000166	0.00193	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—sarcoma	0.000164	0.00191	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—sarcoma	0.000161	0.00187	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—sarcoma	0.000156	0.00181	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—sarcoma	0.000154	0.00179	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—sarcoma	0.000152	0.00177	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—sarcoma	0.000144	0.00168	CcSEcCtD
